Continuous Celiac Plexus Block Decreases Opioid Consumption in Patients with Terminal Visceral Cancer Pain

Share this content:

(ChemotherapyAdvisor) – A marked decrease in visual analog score and in opioid consumption was observed with the use of continuous celiac plexus block, a study in 12 patients reported during the 28th Annual Meeting of the American Academy of Pain Medicine has found.

The patients primarily had pancreatic cancer and had failed conservative measures. Use of continuous celiac plexus block guided by computed tomography resulted in preprocedural mean visual analog score values dropping from 8.7 to 1.8 at the first post-procedural visit; mean morphine use dropped from 155mg/day to 0mg/day during the same period.

“These results persisted during the 6-month follow-up period or until death,” the investigators noted. Moderate diarrhea was observed in three patients and mild hypotension in four. One patient had a transient paraparesis, and no procedure-related mortality was observed.

Abstract

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs